Ero sivun ”Etanersepti” versioiden välillä
| [katsottu versio] | [katsottu versio] |
Poistettu sisältö Lisätty sisältö
Ei muokkausyhteenvetoa |
Ei muokkausyhteenvetoa |
||
Rivi 1:
'''Enbrel''' on lääke joka hoitaa autoimmuunisairauksia TNF-infektoituneilla. is a drug that treats autoimmune diseases by interfering with [[tumor necrosis factor]] (TNF; a soluble inflammatory cytokine) by acting as a [[TNF inhibitor]]. Pfizer describes in a [[U.S. Securities and Exchange Commission|SEC]] filing that the drug is used to treat rheumatoid, juvenile rheumatoid and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Sales reached record $3.3 billion in 2010.<ref>[http://www.sec.gov/Archives/edgar/data/78003/000119312511048877/dex13.htm Sales reached $3b in 2010]</ref>
==Licensed indications==
In the USA the FDA has licenced Enbrel for :
*Moderate to Severe [[Rheumatoid Arthritis]] (RA) (Nov 1998)
*Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) (1999)
*Psoriatic Arthritis (2002)
*[[Ankylosing Spondylitis]] (AS) (July 2003)<ref>http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01240.html FDA</ref>
*Moderate to Severe Plaque Psoriasis (April 2004)
===Viitteet===
| |||